Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1298143

Cover Image

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1298143

U.S. Remote Patient Monitoring Market - Industry Outlook & Forecast 2023-2028

PUBLISHED:
PAGES: 249 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4200
PDF (5 User License)
USD 4999
PDF (Corporate User License)
USD 5999

Add to Cart

The U.S. remote patient monitoring market is expected to grow at a CAGR of 11.16% from 2022 to 2028.

MARKET TRENDS & DRIVERS

Advances in Remote Patient Monitoring Technology

The COVID-19 pandemic has accelerated the growth of the U.S. remote patient monitoring market and has caught the attention of many medical professionals. Recently, IoT-enabled monitoring devices have added offering more functionalities to RPM. By combining AI with the Internet of Things (IoT) and RPM, healthcare organizations and practitioners can better serve their patients and provide opportunities for improved healthcare outcomes.

Increasing Demand for Wireless Patient Monitoring at Home

Over the last few years, home patient monitoring has become a standard of care among adult patients that require a long-term alternative to hospital-based care. The trend toward using a wireless patient monitoring system to monitor vital signs continues to grow. Among many benefits being brought to the healthcare service by wireless patient monitoring is the facility to escalate home care for both chronic and acute conditions. The emergence of new technologies and capabilities makes taking care of one at home possible.

Increasing Focus on Developing Software & Apps for RPM by Manufacturers

Increasing focus on developing software and apps specifically for remote patient monitoring (RPM) by manufacturers is an innovative way to improve and simplify the management of health conditions in both private and public healthcare settings. This ensures that care providers have access to accurate and secure data collected from patients tracked remotely through wearables and connected devices. Manufacturers in the U.S. remote patient monitoring market are investing in this trend by creating apps and software solutions that offer customizable and secure data-driven solutions for RPM. These solutions range from automated patient feedback protocols to machine learning algorithms that better track patient data and behavior. Manufacturers are also offering user-friendly and secure ways for care providers to access more accurate patient data and make informed decisions based on the data. This is creating a new landscape of both secure and efficient RPM services.

The Growing Use of RPM to Monitor & Improve Patient Engagement

Remote patient monitoring (RPM) uses technology to collect, transmit, and review patient-generated data outside the traditional medical care setting. It allows healthcare providers to remotely monitor patients and gain insight into their physical state without having them physically present for a physical check-up. RPM can also detect changes in a patient's condition before they become obvious to the patient and help healthcare providers provide better, more personalized, and timely care. Through RPM, healthcare providers can keep track of patients' medical conditions in real-time and monitor them from a distance. It enables clinicians to identify potentially serious illnesses early and intervene with appropriate treatment. RPM can lead to better outcomes, improved patient engagement, and fewer hospitalizations. RPM also reduces healthcare costs by providing earlier treatment and better managing chronic conditions. Patients benefit from quality care while remaining in their homes with improved access to care and an enhanced overall care experience.

Growing Use of Mobile Technologies & Smart Devices in RPM

Remote patient monitoring uses smartphones, tablets, and other devices to track patient health information constantly. It enables healthcare providers to track a wide range of vital signs such as heart rate, blood pressure, respiratory rate, and body temperature, allowing them to monitor patients from the comfort of their homes. With the growing use of mobile technology, remote patient monitoring can be done on the go. This improves access to care for remote populations and increases efficiency in healthcare delivery. Additionally, it enables real-time remote monitoring of those with chronic illnesses, allowing for timely intervention to prevent further health complications. Mobile technology also ensures data accuracy and consistency, which is critical for effective decision-making and patient care.

SEGMENTATION INSIGHTS

INSIGHTS BY COMPONENT

The U.S. remote patient monitoring market by component is segmented into services, devices & software. In 2022, the software segment accounted for the largest share of the market. Service in the remote patient monitoring market involves using telemetric technology to monitor and collect patient health data from a remote location. This technology allows medical professionals to monitor their patient's health without requiring them to enter a physical medical facility. These services provide access to real-time patient health data, such as blood pressure, blood glucose levels, body temperature, and heart rate. In addition, telemetry technology can also be used to send alerts if an unusual change in vital signs is detected, allowing medical professionals to intervene quickly. This technology allows medical professionals to provide the best care for patients while they are away from the hospital and allows for earlier interventions when needed.

Segmentation by Component

  • Services
  • Devices & Software

INSIGHTS BY APPLICATION

The cardiovascular diseases application segment held the largest U.S. remote patient monitoring market share in 2022, accounting for over 39%. According to the Centers for Disease Control and Prevention (CDC), approximately 11 million patients in the US suffer from cardiac dysrhythmia or arrhythmias. An increase in the prevalence of cardiovascular diseases (CVDs) is one of the factors driving the demand for cardiac monitoring devices. Remote cardiac monitoring has become the norm for patients with heart diseases, especially using implantable cardiac devices. With easy access to real-time telemetry data, cardiologists can determine if a condition represents an emergency illness and create an essentially virtual hospital. In addition, a quarter of health agencies report that RPM reduces visits and readmissions to emergency rooms. Further, the increased use of remote cardiac monitors to improve the detection of hypertension has been the focus of intense research activity in recent years. Remote cardiac monitors provide a viable solution for detecting hypertension at home without cumbersome and intrusive devices and procedures.

Segmentation by Application

  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes
  • Musculoskeletal Diseases
  • Others

INSIGHTS BY END-USER

The U.S. remote patient monitoring market by end-user is segmented into hospitals, home healthcare settings, ambulatory care settings, and long-term care centers. The hospital's segment accounted for the largest share and dominated the segment. The U.S. healthcare system and hospitals plan to improve outcomes and reduce costs through remote patient monitoring (RPM) technology. Hospital settings dominate cardiac monitoring equipment and are the initial point of contact for patients with health challenges. Patients with a history of cardiac arrhythmia are typically treated in hospitals. For the monitoring of CVDs, hospitals have the most up-to-date machines and technology. Though healthcare practitioners are always looking for ways to reduce patients' time in the hospital, the COVID-19 epidemic has increased pressure on physicians to minimize contact time even more to avoid virus exposure. One method that healthcare practitioners are addressing this issue is through remote patient monitoring. By allowing doctors to monitor their patients outside the hospital or doctor's office, they can reduce patients' time in those settings without jeopardizing their health.

Segmentation by End-User

  • Hospitals
  • Home Healthcare Settings
  • Ambulatory Care Settings
  • Long-term Care Centers

REGIONAL ANALYSIS

The southern region accounted for 41% of the U.S. remote patient monitoring market in 2022 and dominated the market. The use of remote patient monitoring in Texas has steadily increased over the past few years. This technology is now being implemented in healthcare organizations across the state to help monitor, manage, and provide patient care more efficiently and effectively. The emergence of remote patient monitoring technology and its steady increase in usage in Texas reflects the state's commitment to providing improved patient care. Remote patient monitoring has been instrumental in cutting costs, as it allows for fewer hospital and clinic visits, thus decreasing the likelihood of patient complications due to prolonged exposure and wait times in an unfamiliar setting.

Segmentation by Region

  • South
    • Texas
    • Florida
    • Virginia
    • Oklahoma
    • New Mexico
  • West
    • California
    • Colorado
    • Nevada
    • Montana
  • Midwest
    • Michigan
    • Illinois
    • Ohio
  • Northeast
    • New York
    • Pennsylvania
    • Massachusetts

COMPETITIVE LANDSCAPE

The U.S. remote patient monitoring market is in a state of intense competition. The industry includes providers of a range of products and services, from diagnosis and treatment to delivery of healthcare applications. Companies operating in this segment are continually forced to innovate and improve to gain a competitive edge. Over the past few years, the U.S. remote patient monitoring market has grown rapidly with the entry of new players and the widespread adoption of technological advances. The focus is shifting towards conquering and expanding the market share from smaller, more localized players to larger, national-scale players. This competition has led to market size, scope growth, and product diversification.

Key Company Profiles

  • AMD Global Telemedicine
  • GE Healthcare
  • Koninklijke Philips
  • Medtronic
  • ResMed
  • Teledoc Health
  • Vivify Health

Other Prominent Vendors

  • 100-Plus
  • Abbott
  • ACL Digital
  • Altumview
  • Baxter
  • Biobeat
  • Biofourmis
  • BIOTRONIK
  • Boston Scientific
  • Cardiologs
  • Cardiomo
  • CAREMINDr
  • CareValidate
  • Datos Health
  • Dexcom
  • Dragerwerk AG
  • F.Hoffmann-La Roche
  • GrandCare Systems
  • Health Recovery Solutions
  • Hinge Health
  • Honeywell International
  • iHealth Unified Care
  • Intel
  • iRhythm Technologies
  • Limber Health
  • Masimo
  • MedM
  • Medopad
  • ModivCare
  • NIHON KOHDEN
  • OMRON
  • OSI Systems
  • OSPLabs
  • Qardio
  • Resideo Technologies
  • Senseonics
  • TeleMedCare
  • Ventricle Health
  • VitalConnect
  • Vitls
  • VivaLNK

KEY QUESTIONS ANSWERED:

  • 1. How big is the U.S. remote patient monitoring market?
  • 2. What is the growth rate of the U.S. remote patient monitoring market?
  • 3. What are the rising trends in the U.S. remote patient monitoring market?
  • 4. Which region holds the most significant U.S. remote patient monitoring market share?
  • 5. Who are the top players in the U.S. remote patient monitoring market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY COMPONENT
    • 4.3.2 MARKET SEGMENTATION BY APPLICATION
    • 4.3.3 MARKET SEGMENTATION BY END-USER
    • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

  • 7.1 OVERVIEW
    • 7.1.1 COMPONENT INSIGHTS
    • 7.1.2 APPLICATION INSIGHTS
    • 7.1.3 END-USER INSIGHTS

8 INTRODUCTION

  • 8.1 BACKGROUND
  • 8.2 REMOTE PATIENT MONITORING: OVERVIEW
  • 8.3 REMOTE PATIENT MONITORING: GLOBAL OUTLOOK
    • 8.3.1 GLOBAL REMOTE PATIENT MONITORING BY GEOGRAPHY
  • 8.4 REMOTE PATIENT MONITORING: GLOBAL VS US OUTLOOK

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY
  • 9.2 INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME
  • 9.3 RISE OF VIRTUAL CLINICAL TRIALS
  • 9.4 AI & IOT DRIVES RPM ADOPTION
  • 9.5 TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING

10 MARKET GROWTH ENABLERS

  • 10.1 INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR RPM BY MANUFACTURERS
  • 10.2 AGING POPULATION & CHRONIC DISORDERS AUGMENTING CONTINUOUS MONITORING DEMAND
  • 10.3 INCREASING INNOVATIONS IN WEARABLE TECHNOLOGY
  • 10.4 GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT
  • 10.5 GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES IN RPM

11 MARKET RESTRAINTS

  • 11.1 REGULATORY VARIATIONS ACROSS US
  • 11.2 LACK OF DATA ACCURACY
  • 11.3 THREAT FROM HEALTHCARE FRAUDS
  • 11.4 ACCESSIBILITY OR CONNECTIVITY OBSTACLES WITH PATIENTS

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
  • 12.3 MARKET OPPORTUNITIES
    • 12.3.1 MARKET BY COMPONENT
    • 12.3.2 MARKET BY APPLICATION
    • 12.3.3 MARKET BY END-USER
  • 12.4 FIVE FORCES ANALYSIS
    • 12.4.1 THREAT OF NEW ENTRANTS
    • 12.4.2 BARGAINING POWER OF SUPPLIERS
    • 12.4.3 BARGAINING POWER OF BUYERS
    • 12.4.4 THREAT OF SUBSTITUTES
    • 12.4.5 COMPETITIVE RIVALRY

13 COMPONENT

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 SERVICES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
  • 13.4 DEVICES & SOFTWARE
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST

14 APPLICATION

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 CARDIOVASCULAR DISEASES
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
  • 14.4 RESPIRATORY DISEASES
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
  • 14.5 DIABETES
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
  • 14.6 MUSCULOSKELETAL DISEASES
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
  • 14.7 OTHERS
    • 14.7.1 MARKET OVERVIEW
    • 14.7.2 MARKET SIZE & FORECAST

15 END-USER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 HOSPITALS
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
  • 15.4 HOME HEALTHCARE SETTINGS
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
  • 15.5 AMBULATORY SURGICAL CENTERS
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
  • 15.6 LONG-TERM CARE CENTERS
    • 15.6.1 MARKET OVERVIEW
    • 15.6.2 MARKET SIZE & FORECAST

16 COMPETITIVE LANDSCAPE

  • 16.1 COMPETITION OVERVIEW
    • 16.1.1 VENDORS ACTIVITIES
  • 16.2 MARKET SHARE ANALYSIS
    • 16.2.1 AMD GLOBAL TELEMEDICINE
    • 16.2.2 GE HEALTHCARE
    • 16.2.3 KONINKLIJKE PHILIPS
    • 16.2.4 MEDTRONIC
    • 16.2.5 RESMED
    • 16.2.6 TELADOC HEALTH
    • 16.2.7 VIVIFY HEALTH

17 KEY COMPANY PROFILES

  • 17.1 AMD GLOBAL TELEMEDICINE
    • 17.1.1 BUSINESS OVERVIEW
    • 17.1.2 PRODUCT OFFERINGS
    • 17.1.3 KEY STRATEGIES
    • 17.1.4 KEY STRENGTHS
    • 17.1.5 KEY OPPORTUNITIES
  • 17.2 GE HEALTHCARE
    • 17.2.1 BUSINESS OVERVIEW
    • 17.2.2 PRODUCT OFFERINGS
    • 17.2.3 KEY STRATEGIES
    • 17.2.4 KEY STRENGTHS
    • 17.2.5 KEY OPPORTUNITIES
  • 17.3 KONINKLIJKE PHILIPS
    • 17.3.1 BUSINESS OVERVIEW
    • 17.3.2 PRODUCT OFFERINGS
    • 17.3.3 KEY STRATEGIES
    • 17.3.4 KEY STRENGTHS
    • 17.3.5 KEY OPPORTUNITIES
  • 17.4 MEDTRONIC
    • 17.4.1 BUSINESS OVERVIEW
    • 17.4.2 PRODUCT OFFERINGS
    • 17.4.3 KEY STRATEGIES
    • 17.4.4 KEY STRENGTHS
    • 17.4.5 KEY OPPORTUNITIES
  • 17.5 RESMED
    • 17.5.1 BUSINESS OVERVIEW
    • 17.5.2 PRODUCT OFFERING
    • 17.5.3 KEY STRATEGIES
    • 17.5.4 KEY STRENGTHS
    • 17.5.5 KEY OPPORTUNITIES
  • 17.6 TELADOC HEALTH
    • 17.6.1 BUSINESS OVERVIEW
    • 17.6.2 PRODUCT OFFERINGS
    • 17.6.3 KEY STRATEGIES
    • 17.6.4 KEY STRENGTHS
    • 17.6.5 KEY OPPORTUNITIES
  • 17.7 VIVIFY HEALTH
    • 17.7.1 BUSINESS OVERVIEW
    • 17.7.2 PRODUCT OFFERING
    • 17.7.3 KEY STRATEGIES
    • 17.7.4 KEY STRENGTHS
    • 17.7.5 KEY OPPORTUNITIES

18 OTHER PROMINENT VENDORS

  • 18.1 100-PLUS
    • 18.1.1 BUSINESS OVERVIEW
    • 18.1.2 PRODUCT OFFERINGS
  • 18.2 ABBOTT
    • 18.2.1 BUSINESS OVERVIEW
    • 18.2.2 PRODUCT OFFERINGS
  • 18.3 ACL DIGITAL
    • 18.3.1 BUSINESS OVERVIEW
    • 18.3.2 PRODUCT OFFERINGS
  • 18.4 ALTUMVIEW
    • 18.4.1 BUSINESS OVERVIEW
    • 18.4.2 PRODUCT OFFERINGS
  • 18.5 BAXTER
    • 18.5.1 BUSINESS OVERVIEW
    • 18.5.2 PRODUCT OFFERINGS
  • 18.6 BIOBEAT
    • 18.6.1 BUSINESS OVERVIEW
    • 18.6.2 PRODUCT OFFERINGS
  • 18.7 BIOFOURMIS
    • 18.7.1 BUSINESS OVERVIEW
    • 18.7.2 PRODUCT OFFERING
  • 18.8 BIOTRONIK
    • 18.8.1 BUSINESS OVERVIEW
    • 18.8.2 PRODUCT OFFERING
  • 18.9 BOSTON SCIENTIFIC
    • 18.9.1 BUSINESS OVERVIEW
    • 18.9.2 PRODUCT OFFERINGS
  • 18.10 CARDIOLOGS
    • 18.10.1 BUSINESS OVERVIEW
    • 18.10.2 PRODUCT OFFERINGS
  • 18.11 CARDIOMO
    • 18.11.1 BUSINESS OVERVIEW
    • 18.11.2 PRODUCT OFFERINGS
  • 18.12 CAREMINDR
    • 18.12.1 BUSINESS OVERVIEW
    • 18.12.2 PRODUCT OFFERING
  • 18.13 CAREVALIDATE
    • 18.13.1 BUSINESS OVERVIEW
    • 18.13.2 PRODUCT OFFERINGS
  • 18.14 CLEARARCH
    • 18.14.1 BUSINESS OVERVIEW
    • 18.14.2 PRODUCT OFFERINGS
  • 18.15 DATOS HEALTH
    • 18.15.1 BUSINESS OVERVIEW
    • 18.15.2 PRODUCT OFFERINGS
  • 18.16 DEXCOM
    • 18.16.1 BUSINESS OVERVIEW
    • 18.16.2 PRODUCT OFFERING
  • 18.17 DRAGERWERK AG
    • 18.17.1 BUSINESS OVERVIEW
    • 18.17.2 PRODUCT OFFERINGS
  • 18.18 F. HOFFMANN-LA ROCHE
    • 18.18.1 BUSINESS OVERVIEW
    • 18.18.2 PRODUCT OFFERINGS
  • 18.19 GRANDCARE SYSTEMS
    • 18.19.1 BUSINESS OVERVIEW
    • 18.19.2 PRODUCT OFFERINGS
  • 18.20 HEALTH RECOVERY SOLUTIONS
    • 18.20.1 BUSINESS OVERVIEW
    • 18.20.2 PRODUCT OFFERINGS
  • 18.21 HINGE HEALTH
    • 18.21.1 BUSINESS OVERVIEW
    • 18.21.2 PRODUCT OFFERINGS
  • 18.22 HONEYWELL INTERNATIONAL
    • 18.22.1 BUSINESS OVERVIEW
    • 18.22.2 PRODUCT OFFERINGS
  • 18.23 IHEALTH UNIFIED CARE
    • 18.23.1 BUSINESS OVERVIEW
    • 18.23.2 PRODUCT OFFERINGS
  • 18.24 INTEL
    • 18.24.1 BUSINESS OVERVIEW
    • 18.24.2 PRODUCT OFFERING
  • 18.25 IRHYTHM TECHNOLOGIES
    • 18.25.1 BUSINESS OVERVIEW
    • 18.25.2 PRODUCT OFFERING
  • 18.26 LIMBER HEALTH
    • 18.26.1 BUSINESS OVERVIEW
    • 18.26.2 PRODUCT OFFERINGS
  • 18.27 MASIMO
    • 18.27.1 BUSINESS OVERVIEW
    • 18.27.2 PRODUCT OFFERINGS
  • 18.28 MEDM
    • 18.28.1 BUSINESS OVERVIEW
    • 18.28.2 PRODUCT OFFERING
  • 18.29 MEDOPAD
    • 18.29.1 BUSINESS OVERVIEW
    • 18.29.2 PRODUCT OFFERINGS
  • 18.30 MODIVCARE
    • 18.30.1 BUSINESS OVERVIEW
    • 18.30.2 PRODUCT OFFERINGS
  • 18.31 NIHON KOHDEN
    • 18.31.1 BUSINESS OVERVIEW
    • 18.31.2 PRODUCT OFFERINGS
  • 18.32 OMRON
    • 18.32.1 BUSINESS OVERVIEW
    • 18.32.2 PRODUCT OFFERINGS
  • 18.33 OSI SYSTEMS
    • 18.33.1 BUSINESS OVERVIEW
    • 18.33.2 PRODUCT OFFERINGS
  • 18.34 OSPLABS
    • 18.34.1 BUSINESS OVERVIEW
    • 18.34.2 PRODUCT OFFERINGS
  • 18.35 QARDIO
    • 18.35.1 BUSINESS OVERVIEW
    • 18.35.2 PRODUCT OFFERING
  • 18.36 SENSEONICS
    • 18.36.1 BUSINESS OVERVIEW
    • 18.36.2 PRODUCT OFFERINGS
  • 18.37 TELEMEDCARE
    • 18.37.1 BUSINESS OVERVIEW
    • 18.37.2 PRODUCT OFFERINGS
  • 18.38 VENTRICLE HEALTH
    • 18.38.1 BUSINESS OVERVIEW
    • 18.38.2 PRODUCT OFFERINGS
  • 18.39 VITALCONNECT
    • 18.39.1 PRODUCT OFFERINGS
  • 18.40 VITLS
    • 18.40.1 BUSINESS OVERVIEW
    • 18.40.2 PRODUCT OFFERINGS
  • 18.41 VIVALNK
    • 18.41.1 BUSINESS OVERVIEW
    • 18.41.2 PRODUCT OFFERINGS

19 REPORT SUMMARY

  • 19.1 KEY TAKEAWAYS
  • 19.2 STRATEGIC RECOMMENDATIONS

20 QUANTITATIVE SUMMARY

  • 20.1 MARKET BY COMPONENT
  • 20.2 MARKET BY APPLICATION
  • 20.3 MARKET BY END-USER
  • 20.4 HOME HEALTHCARE SETTINGS BY REGION
  • 20.5 HOME HEALTHCARE SETTINGS BY COMPONENT
  • 20.6 HOME HEALTHCARE SETTINGS BY APPLICATION

21 APPENDIX

  • 21.1 ABBREVIATIONS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!